CABALETTA BIO INC
CABA · NASDAQ
Updated at 2026-10-14 09:03:13
- Today's High
- $1.82
- Today’s Low
- $1.59
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.94
- Previous Close
- $1.79
- Volume
- 4.83M
- Market Cap
- $303.48M
- P/E Ratio
- --
- EPS
- $-1.56
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 2929 ARCH STREET, PHILADELPHIA, PA, UNITED STATES, 19104
- Country
- US
- Listing Date
- 2019-10-25
- Fiscal Year End
- December
- Shares Outstanding
- 163.05M
- CIK
- 0001759138
- Website
- www.cabalettabio.com
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of T-cell therapies designed for patients with B-cell-mediated autoimmune diseases. The company is headquartered in Philadelphia, Pennsylvania.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$52.02M
2026-03-31
$44.29M
2025-12-31
$42.61M
2025-09-30
$46.58M
Net Income
2026-06-30
-$51.01M
2026-03-31
-$43.51M
2025-12-31
-$41.91M
2025-09-30
-$44.86M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.34
2026-03-31
$-0.39
2025-12-31
$-0.40
2025-09-30
$-0.44
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$50.13M
2026-03-31
-$42.54M
2025-12-31
-$41.01M
2025-09-30
-$43.93M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $52.02M | $44.29M | $42.61M | $46.58M |
| Net Income | -$51.01M | -$43.51M | -$41.91M | -$44.86M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.34 | $-0.39 | $-0.40 | $-0.44 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$50.13M | -$42.54M | -$41.01M | -$43.93M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.